Effect of Roux-en-Y Gastric Bypass for Patients with Type 2 Diabetes Mellitus and a BMI < 32.5 kg/m2: a 6-Year Study in Chinese Patients.

Obesity Surgery
Guangnian JiShaihong Zhu

Abstract

Roux-en-Y gastric bypass (RYGB) is an effective treatment for morbidly obese patients to improve type 2 diabetes mellitus (T2DM). Recently, T2DM patients with a lower body mass index (BMI) have been receiving more attention, and these patients could benefit from RYGB. Fifty-two patients with T2DM underwent RYGB between October 2008 and December 2012 in our hospital. Weight, BMI, oral glucose tolerance test (OGTT), insulin release test (IRT), C-peptide release test (CRT), glycosylated hemoglobin (HbA1c), and lipid metabolic parameters were measured at baseline and at 3 and 6 months and 1, 2, 3, 4, 5, and 6 years after surgery. The mean age of the 52 patients was 46.8 ± 9.5 years, and 57.7% were male. The mean duration of T2DM was 6.5 ± 4.6 years. Compared with the baseline values, weight and BMI were significantly decreased at several time points after surgery. HbA1c decreased from 8.2 ± 1.7% at baseline to 6.5 ± 1.4% at 3 months, 6.5 ± 1.4% at 6 months, 7.2 ± 1.3% at 4 years, and 7.5 ± 1.2% at 6 years. OGTT, OGTT-IRT, and OGTT-CRT improved after surgery. There was a decrease in triglycerides (TGs), total cholesterol (TC), and low-density lipoprotein (LDL) and an increase in high-density lipoprotein (HDL). At 6 years after surge...Continue Reading

References

Oct 14, 2004·JAMA : the Journal of the American Medical Association·Henry BuchwaldKaren Schoelles
Dec 29, 2006·Diabetes Care·UNKNOWN American Diabetes Association
Mar 11, 2009·The American Journal of Medicine·Henry BuchwaldIsabella Sledge
Oct 23, 2009·Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery·Shashank S ShahDavid E Cummings
Oct 31, 2009·Lancet·Ambady RamachandranChamukuttan Snehalatha
Oct 31, 2009·Diabetes Care·John B BuseM Sue Kirkman
Jul 26, 2011·Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery·J B DixonUNKNOWN International Diabetes Federation Taskforce on Epidemiology and Prevention
Nov 2, 2011·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Wei-Jei LeeYi-Chih Lee
Jan 3, 2013·Diabetic Medicine : a Journal of the British Diabetic Association·J B DixonP Zimmet
Sep 5, 2013·JAMA : the Journal of the American Medical Association·Yu XuUNKNOWN 2010 China Noncommunicable Disease Surveillance Group
Mar 22, 2014·Obesity Surgery·Nicola ScopinaroRenzo Cordera
Dec 31, 2014·Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery·Haoyong YuWeiping Jia
Jun 30, 2015·Diabetes Research and Clinical Practice· Idf Diabetes Atlas Group
May 26, 2016·Diabetes Care·Rachel L Batterham, David E Cummings
Oct 11, 2016·Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery·Xiao DuZhong Cheng

❮ Previous
Next ❯

Citations

Dec 29, 2020·Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery·Zhigang KeWeidong Tong
Aug 4, 2021·Obesity Surgery·Wah YangUNKNOWN Chinese Obesity and Metabolic Surgery Collaborative

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Related Papers

Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
Alfonso TorquatiWilliam O Richards
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery
Brian E KaderaEric J DeMaria
© 2021 Meta ULC. All rights reserved